We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$660M
AUM Growth
+$3.27M
Cap. Flow
-$5.55M
Cap. Flow %
-0.84%
Top 10 Hldgs %
37.72%
Holding
128
New
6
Increased
27
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$14.7M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$5.15M
3
COP icon
ConocoPhillips
COP
+$4.54M
4
FTI icon
TechnipFMC
FTI
+$455K
5
MRK icon
Merck
MRK
+$354K

Top Sells

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$16.6M
2
CMD
Cantel Medical Corporation
CMD
+$9.35M
3
LLY icon
Eli Lilly
LLY
+$2.25M
4
MJN
Mead Johnson Nutrition Company
MJN
+$1.34M
5
BMY icon
Bristol-Myers Squibb
BMY
+$490K

Sector Composition

Rank Sector Weight
1 Industrials 18.86%
2 Financials 14.21%
3 Healthcare 12.56%
4 Consumer Discretionary 12.5%
5 Communication Services 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD
26
DELISTED
Du Pont De Nemours E I
DD
$10.6M 1.61%
131,420
– –
PNC icon
27
PNC Financial Services
PNC
$100B
$9.9M 1.5%
79,295
+530
+0.7% +$63.9K
V icon
28
Visa
V
$677B
$9.78M 1.48%
104,317
+1,150
+1% +$107K
SWKS icon
29
Skyworks Solutions
SWKS
$9.06B
$9.76M 1.48%
101,758
+675
+0.7% +$69.2K
EMR icon
30
Emerson Electric
EMR
$82.9B
$9.17M 1.39%
153,785
– –
SLB icon
31
SLB Ltd
SLB
$78.4B
$8.88M 1.35%
134,816
-510
-0.4% -$36.5K
CAC icon
32
Camden National
CAC
$924M
$8.77M 1.33%
204,254
-1,320
-0.6% -$55.7K
DOV icon
33
Dover
DOV
$27.2B
$8.09M 1.23%
124,790
– –
CVX icon
34
Chevron
CVX
$388B
$7.17M 1.09%
68,768
+577
+0.8% +$61.1K
NSC icon
35
Norfolk Southern
NSC
$78.8B
$6.84M 1.04%
56,200
– –
GOOG icon
36
Alphabet (Google) Class C
GOOG
$3.9T
$6.43M 0.98%
141,620
+900
+0.6% +$41.2K
FN icon
37
Fabrinet
FN
$17.1B
$6.19M 0.94%
145,000
+3,100
+2% +$117K
RDS.A
38
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$5.82M 0.88%
109,465
-1,200
-1% -$64.3K
XBI icon
39
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$5.61M 0.85%
+72,640
New +$5.15M
KIM icon
40
Kimco Realty
KIM
$17.6B
$5.57M 0.84%
303,592
– –
MCD icon
41
McDonald's
MCD
$188B
$5.46M 0.83%
35,616
– –
MTB icon
42
M&T Bank
MTB
$36.2B
$5.19M 0.79%
32,034
– –
DD icon
43
DuPont de Nemours
DD
$18.6B
$4.97M 0.75%
31,135
– –
HON icon
44
Honeywell
HON
$77B
$4.79M 0.73%
39,777
– –
COP icon
45
ConocoPhillips
COP
$147B
$4.79M 0.73%
108,900
+97,350
+843% +$4.54M
PEP icon
46
PepsiCo
PEP
$186B
$4.04M 0.61%
34,990
– –
OXY icon
47
Occidental Petroleum
OXY
$57B
$3.89M 0.59%
64,995
+1,050
+2% +$64.3K
BMY icon
48
Bristol-Myers Squibb
BMY
$127B
$3.27M 0.5%
58,748
-9,000
-13% -$490K
T icon
49
AT&T
T
$165B
$2.97M 0.45%
104,261
+1,258
+1% +$37.1K
NEE icon
50
NextEra Energy
NEE
$187B
$2.93M 0.44%
83,628
– –
1
2
3 4 5

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q2 2017 Portfolio in Review

As of Q2 2017, Kimelman & Baird held 128 positions worth $660M, up 0.5% from $657M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Kimelman & Baird's Q2 2017 filing shows 6 new, 27 increased, 22 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M. The largest sale was Copart, an estimated $16.6M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Kimelman & Baird's largest Q2 2017 buy was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M.
  • Kimelman & Baird added most to Costco in Q2 2017, an estimated $14.7M increase.
  • Kimelman & Baird's biggest Q2 2017 reduction was Copart, cutting an estimated $16.6M.
  • Kimelman & Baird fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $1.34M.
  • Kimelman & Baird's ten largest holdings make up 38% of its $660M portfolio in Q2 2017.
  • Kimelman & Baird opened 6 new positions and closed 7 in Q2 2017.
  • Kimelman & Baird's portfolio value rose 0.5% quarter-over-quarter to $660M.

Based on Kimelman & Baird's 13F filing for Q2 2017, filed 22 Aug 2017.